Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending SPRY Q1 2026 Earnings EPS Miss and Continued Cash Burn Amid Pipeline Development POOL Q1 2026 Earnings EPS Beats Estimates as Demand Holds Steady Purple Biotech Ltd PPBT Q1 2025 Earnings PreRevenue Biotech Reports Narrower Loss as Clinical Progress Continues InfuSystems Holdings INFU Q1 2026 Earnings Strong EPS Beat Masks Revenue Uncertainty KPRX Q1 2026 Earnings NarrowerThanExpected Loss Drives Optimism Despite Revenue Gap